COMMUNIQUÉS West-GlobeNewswire

Neuphoria Provides First Quarter 2025 Business Updates
20/05/2025
Cash runway into Q3 2026 AFFIRM-1 Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout in Q3 2025 α7 nicotinic acetylcholine receptor PAM MK-1167 partnered with Merck and in Phase 2 [...]
Fitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Growth Strategy
20/05/2025
TEL AVIV, Israel, May 20, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals (NYSE and TASE: TEVA) today announced that Fitch Ratings Agency (“Fitch”) has raised the Company's corporate credit rating to BB+, with a stable [...]
TrialWire the AI and Algorithm-powered Platform Named a Fierce CRO Award Finalist in the “Outstanding Patient Recruitment and Retention” Category
20/05/2025
TrialWire™ is the risk-share pay-per-enrolled AI and algorithm-powered patient recruitment Platform built on Salesforce Health Cloud for industry-leading patient data and IP security SAN FRANCISCO, May 20, 2025 (GLOBE [...]
Global Alzheimer’s Platform Foundation Applauds FDA Authorization of the First Blood-Based Diagnostic Test for Assessing Alzheimer’s Disease
20/05/2025
WASHINGTON, May 20, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation ® (GAP) applauds the FDA's clearance of the first blood test to diagnose Alzheimer’s disease . Fujirebio’s Lumipulse G pTau217/ß- [...]
Segra International Acquires Klonetics to Expand Nursery Capacity and Accelerate Growth
20/05/2025
VANCOUVER, British Columbia, May 20, 2025 (GLOBE NEWSWIRE) -- Segra International (“Segra”), a global leader in cannabis agriculture technology, proudly announces its strategic amalgamation with Klonetics Plant Science [...]
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
20/05/2025
NOVATO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare [...]
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/05/2025
SOUTH SAN FRANCISCO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the “Company” or “Vaxart”) today announced that the Compensation Committee of the Board of Directors approved certain equity [...]
Teva Announces Successful Upsizing and Pricing of $2,300,000,000 (Equivalent) Senior Notes; Proceeds to Repay Existing Debt
20/05/2025
TEL AVIV, Israel, May 20, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“ Teva ”) announced today that it successfully upsized its offering and priced approximately $2,300,000,000 ( [...]
MedX Holdings, Inc. (OTC: MEDH) Announces Record Q1 2025 Revenue and Strategic Advances Across Cannabis, Retail Tech, and Franchise Growth
20/05/2025
Austin, Texas, May 20, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE MedX Holdings, Inc. (OTC: MEDH) Reports Record Q1 2025 Revenue and Announces Strategic Milestones in Retail Technology, AI, and Cannabis Expansion [...]
Roche provides update on FDA Advisory Committee meeting on Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma
20/05/2025
Columvi is the first bispecific antibody to show a statistically significant and clinically meaningful 41% survival benefit in R/R DLBCL in the phase III STARGLO study 1,2 There is an urgent need for effective, [...]
AscellaHealth to Present on Site of Care Strategies for High-Cost Medications at SIIA Stakeholder Forum
20/05/2025
BERWYN, Pa., May 20, 2025 (GLOBE NEWSWIRE) -- AscellaHealth , a global partner delivering customizable solutions to support the specialty pharmaceutical industry, is excited to announce its participation in the Self- [...]
Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting
20/05/2025
Pratteln, Switzerland, May 20, 2025 – Santhera Pharmaceuticals (SIX: SANN) today announces that its shareholders approved all motions by the Board of Directors at the Annual General Meeting (AGM) held today in Pratteln [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 30 avril 2025
20/05/2025
Nombre total de droits de vote et d’actions composant le capital social au 30 avril 2025 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2025
20/05/2025
Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2025 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
20/05/2025
Company Announcement COPENHAGEN, Denmark; May 20, 2025 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 1,746 shares as a consequence of the exercise of employee warrants. The increase is effected without [...]
VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer
20/05/2025
Industry Veteran to Support Acceleration of Key Pipeline Projects and Novel BiTAC™ Antibody Formats Towards Clinical Studies ZURICH, May 20, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (“VERAXA”), an emerging leader in [...]
Devereux Georgia expands foster care services to Savannah
20/05/2025
Nonprofit to provide critical support for foster youth and families in the coastal Savannah region KENNESAW, Ga., May 20, 2025 (GLOBE NEWSWIRE) -- Devereux Advanced Behavioral Health Georgia today announced it is now [...]
Philikos announces initiation of clinical Phase 1/2 study with T-Guard® in patients with systemic sclerosis
20/05/2025
NIJMEGEN, the Netherlands, May 20, 2025 (GLOBE NEWSWIRE) -- Philikos B.V., a Dutch biotechnology company developing antibody-based therapies to treat severe immune disorders, today announced that it has enrolled the [...]
Enlivex Selected to Present at Israeli BioMed 2025 Conference
20/05/2025
Presentation to highlight Allocetra™ and the therapeutic potential of macrophage reprogramming in inflammatory diseases Ness-Ziona, Israel, May 20, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “ [...]

Pages